Salud financiera de hoja de balance de NeuPath Health

Salud financiera controles de criterios 5/6

NeuPath Health tiene un patrimonio de accionistas total de CA$21.6M y una deuda total de CA$5.7M, lo que sitúa su ratio deuda-patrimonio en 26.6%. Sus activos y pasivos totales son CA$41.7M y CA$20.1M respectivamente. El BAIT de NeuPath Health es de CA$1.1M, por lo que su ratio de cobertura de intereses es de 1.2. Tiene efectivo e inversiones a corto plazo que ascienden a CA$3.1M.

Información clave

26.6%

Ratio deuda-patrimonio

CA$5.74m

Deuda

Ratio de cobertura de intereses	1.2x
Efectivo	CA$3.14m
Patrimonio	CA$21.62m
Total pasivo	CA$20.13m
Activos totales	CA$41.75m

Actualizaciones recientes sobre salud financiera

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CA$11.2M) de NPTH no cubren sus pasivos a corto plazo (CA$11.7M).

Pasivo a largo plazo: Los activos a corto plazo de NPTH (CA$11.2M) superan a sus pasivos a largo plazo (CA$8.5M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (12%) de NPTH se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de NPTH ha pasado de 141.2% a 26.6% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable NPTH tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: NPTH no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 46.5% al año.

Salud financiera de hoja de balance de NeuPath Health

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.007 profit in 3Q 2023)

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Second quarter 2024 earnings released: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

First quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 1Q 2023)

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

NeuPath Health Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.002 loss per share (vs CA$0.086 loss in FY 2022)

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Third quarter 2023 earnings released: EPS: CA$0.007 (vs CA$0.022 loss in 3Q 2022)

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH).

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Second quarter 2023 earnings released: EPS: CA$0.001 (vs CA$0.007 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.019 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.086 loss per share (vs CA$0.072 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.022 loss per share (vs CA$0.014 loss in 3Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc Announces Board Changes

NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.025 loss in 2Q 2021)

NeuPath Health Inc. Announces Grant Connelly Step Down from Chief Executive Officer, on or Before August 19, 2022

First quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.016 loss in 1Q 2021)

High number of new and inexperienced directors

NeuPath Health Inc., Annual General Meeting, Jun 22, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.01 loss in 3Q 2020)

NeuPath Health Inc. (TSXV:NPTH) completed the acquisition of KumoCare Inc.

Second quarter 2021 earnings released

CFO & Corporate Secretary Stephen Lemieux has left the company

NeuPath Health Inc. (TSXV:NPTH) agreed to acquire KumoCare Inc. for $1.1 million.

First quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.05 loss in 1Q 2020)

NeuPath Health Inc. Announces Revenue Guidance for the First Quarter of 2021

Full year 2020 earnings released

NeuPath Health Inc. (TSXV:NPTH) acquired Healthpointe Medical Centres Ltd. for CAD 6.7 million.

New 90-day low: CA$0.72

New 90-day low: CA$0.75

NeuPath Health Inc. has completed a Composite Units Offering in the amount of CAD 10.44 million.

New 90-day high: CA$1.10

Insider recently bought CA$60k worth of stock

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera